Balas, Bogdana
F. Hoffmann-La Roche AG · Seoul National University · University of California, Irvine · University of Michigan · Centre Hospitalier Universitaire Vaudois · Massachusetts General Hospital · Sungkyunkwan University · University of Colorado Denver
2 papers on CoChatORCID 0000-0003-0999-6185
Most cited papers
- Verified
Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer
Peters, S., Camidge, D. R., Shaw, A. T., Gadgeel, S., Ahn, J. S., Kim, D.-W., Ou, S.-H. I., Pérol, M., Dziadziuszko, R., Rosell, R., et al. (2017) · New England Journal of Medicine
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 2,527
- Verified
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Shaw, A. T., Gandhi, L., Gadgeel, S., Riely, G. J., Cetnar, J., West, H., Camidge, D. R., Socinski, M. A., Chiappori, A., Mekhail, T., et al. (2016) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 638
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free